Invivyd (IVVD) Operating Leases (2022 - 2025)

Invivyd (IVVD) reported Operating Leases of $1.2 million for Q4 2025, down 31.07% on a YoY basis from $1.7 million in Q4 2024, and down 24.72% quarter-over-quarter from $1.6 million in Q3 2025.

Invivyd (IVVD) Operating Leases (2022 - 2025) Analysis & Trends

Invivyd has reported Operating Leases for 4 years, with the latest figure at $1.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 31.07% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (down 31.07% YoY), and the FY2025 full-year result was $1.2 million, down 31.07% from the prior year.
  • Operating Leases for Q4 2025 stood at $1.2 million, down from $1.6 million in the prior quarter.
  • The five-year high for Operating Leases was $1.9 million in Q2 2022, with the low at $100000.0 in Q1 2022.
  • Historically, Operating Leases has averaged $1.1 million across 4 years, with a median of $1.2 million in 2022.
  • Annual changes were most pronounced in 2024 — Operating Leases sank 76.38% — and 2025, when it surged 627.85%.
  • Invivyd's Operating Leases stood at $837000.0 in 2022, then soared by 106.81% to $1.7 million in 2023, then gained by 0.58% to $1.7 million in 2024, then slumped by 31.07% to $1.2 million in 2025.
  • The last three Operating Leases figures came in at $1.2 million (Q4 2025), $1.6 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Invivyd 168.41 Mn -58.28 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.20 Mn
Sep 30, 2025 1.59 Mn
Jun 30, 2025 1.90 Mn
Mar 31, 2025 425,000.00
Dec 31, 2024 1.74 Mn
Sep 30, 2024 219,000.00
Mar 31, 2024 435,000.00
Dec 31, 2023 1.73 Mn
Sep 30, 2023 927,000.00
Jun 30, 2023 1.30 Mn
Mar 31, 2023 432,000.00
Dec 31, 2022 837,000.00
Sep 30, 2022 1.18 Mn
Jun 30, 2022 1.90 Mn
Mar 31, 2022 100,000.00